BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 29106804)

  • 1. Targeting RAGE Signaling in Inflammatory Disease.
    Hudson BI; Lippman ME
    Annu Rev Med; 2018 Jan; 69():349-364. PubMed ID: 29106804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors.
    Kim HJ; Jeong MS; Jang SB
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34199060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ousting RAGE in melanoma: A viable therapeutic target?
    Syed DN; Aljohani A; Waseem D; Mukhtar H
    Semin Cancer Biol; 2018 Apr; 49():20-28. PubMed ID: 29079306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging.
    Teissier T; Boulanger É
    Biogerontology; 2019 Jun; 20(3):279-301. PubMed ID: 30968282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alarmins in Osteoporosis, RAGE, IL-1, and IL-33 Pathways: A Literature Review.
    De Martinis M; Ginaldi L; Sirufo MM; Pioggia G; Calapai G; Gangemi S; Mannucci C
    Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32204562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.
    Yan SF; Ramasamy R; Schmidt AM
    J Mol Med (Berl); 2009 Mar; 87(3):235-47. PubMed ID: 19189073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.
    Reynaert NL; Gopal P; Rutten EPA; Wouters EFM; Schalkwijk CG
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):403-418. PubMed ID: 27373680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMGB1 and RAGE in inflammation and cancer.
    Sims GP; Rowe DC; Rietdijk ST; Herbst R; Coyle AJ
    Annu Rev Immunol; 2010; 28():367-88. PubMed ID: 20192808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of damage- and pathogen-associated molecular patterns in inflammation-mediated vulnerability of atherosclerotic plaques.
    Rai V; Agrawal DK
    Can J Physiol Pharmacol; 2017 Oct; 95(10):1245-1253. PubMed ID: 28746820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The false alarm hypothesis: Food allergy is associated with high dietary advanced glycation end-products and proglycating dietary sugars that mimic alarmins.
    Smith PK; Masilamani M; Li XM; Sampson HA
    J Allergy Clin Immunol; 2017 Feb; 139(2):429-437. PubMed ID: 27544741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of RAGE in host pathology and crosstalk between RAGE and TLR4 in innate immune signal transduction pathways.
    Prantner D; Nallar S; Vogel SN
    FASEB J; 2020 Dec; 34(12):15659-15674. PubMed ID: 33131091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting receptors of advanced glycation end products (RAGE): Preventing diabetes induced cancer and diabetic complications.
    Chhipa AS; Borse SP; Baksi R; Lalotra S; Nivsarkar M
    Pathol Res Pract; 2019 Nov; 215(11):152643. PubMed ID: 31564569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential of Targeting the HMGB1/RAGE Axis in Inflammatory Diseases.
    Singh H; Agrawal DK
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RAGE/multiligand axis: a new actor in tumor biology.
    Rojas A; Schneider I; Lindner C; Gonzalez I; Morales MA
    Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35727208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAGE and its ligands: from pathogenesis to therapeutics.
    Jangde N; Ray R; Rai V
    Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):555-575. PubMed ID: 32933340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases.
    Yue Q; Song Y; Liu Z; Zhang L; Yang L; Li J
    Molecules; 2022 Aug; 27(15):. PubMed ID: 35956875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AGEs, RAGEs and s-RAGE; friend or foe for cancer.
    Ahmad S; Khan H; Siddiqui Z; Khan MY; Rehman S; Shahab U; Godovikova T; Silnikov V; Moinuddin
    Semin Cancer Biol; 2018 Apr; 49():44-55. PubMed ID: 28712719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAGE and TLRs: relatives, friends or neighbours?
    Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
    Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.
    Prasad K
    Mol Cell Biochem; 2019 Sep; 459(1-2):95-112. PubMed ID: 31079281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role and Mechanisms of RAGE-Ligand Complexes and RAGE-Inhibitors in Cancer Progression.
    El-Far AH; Sroga G; Jaouni SKA; Mousa SA
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.